Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Fungal Diseases”

1,284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,284 results

Not applicableUnknownNCT03549052
What this trial is testing

Right Ventricular Echo Assessment in Mitral Valve Replacement

Who this might be right for
Right Ventricular DysfunctionRheumatic Heart Disease
Assiut University 120
Early research (Phase 1)Study completedNCT06224608
What this trial is testing

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Chengdu CoenBiotech Co., Ltd 60
Testing effectiveness (Phase 2)Study completedNCT01375049
What this trial is testing

Aztreonam Lysine for Pseudomonas Infection Eradication Study

Who this might be right for
Cystic Fibrosis
Gilead Sciences 105
Large-scale testing (Phase 3)Ended earlyNCT01110421
What this trial is testing

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Who this might be right for
Pneumonia, BacterialCommunity-Acquired InfectionsNosocomial Infection+1 more
Janssen Research & Development, LLC 7
Not applicableLooking for participantsNCT06585358
What this trial is testing

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Karolinska Institutet 30
Large-scale testing (Phase 3)Study completedNCT00509106
What this trial is testing

Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Forest Laboratories 622
Not applicableStudy completedNCT03072576
What this trial is testing

Accuracy and Feasibility of Xpert Ultra

Who this might be right for
Tuberculosis, Pulmonary
Foundation for Innovative New Diagnostics, Switzerland 1,400
Early research (Phase 1)Study completedNCT00111397
What this trial is testing

Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection

Who this might be right for
Mycobacterium Avium-Intracellulare Infection
National Institute of Allergy and Infectious Diseases (NIAID) 2
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Testing effectiveness (Phase 2)Study completedNCT02453789
What this trial is testing

OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

Who this might be right for
Cystic FibrosisBurkholderia Infection
AlgiPharma AS 15
Testing effectiveness (Phase 2)Looking for participantsNCT06511050
What this trial is testing

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Who this might be right for
Long CovidPost-treatment Lyme Disease SyndromeChronic Fatigue Syndrome+1 more
Icahn School of Medicine at Mount Sinai 120
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableWithdrawnNCT03277742
What this trial is testing

Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz

Who this might be right for
Pulmonary TuberculosisDiabetes Mellitus, Type 2
Instituto Nacional de Salud Publica, Mexico
Not applicableLooking for participantsNCT05426720
What this trial is testing

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

Who this might be right for
Pulmonary TB
Peking University Third Hospital 400
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Very early researchLooking for participantsNCT07830771
What this trial is testing

Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
University of Pennsylvania 10
Testing effectiveness (Phase 2)Study completedNCT05412030
What this trial is testing

Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

Who this might be right for
Pneumonia, BacterialPneumococcal InfectionsPneumonia, Pneumococcal
GlaxoSmithKline 388
Post-approval studies (Phase 4)UnknownNCT02901288
What this trial is testing

Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Beijing Chest Hospital 3,900
Not applicableStudy completedNCT02569879
What this trial is testing

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

Who this might be right for
DiphtheriaAcellular PertussisTetanus+2 more
GlaxoSmithKline 1
Next Page